A clinical trial to study the safety and effect of the siddha medicine kattu karunai chooranam in patients having haemorrhoids (Mulai Moolam)

Phase II Non randomised open clinical evaluation of siddha medicine kattu karunai chooranam for mulai moolam ( Haemorrhoids) - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/027446

Enrollment

Registered

2020-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K640- First degree hemorrhoids

Interventions

Intervention1: Kattu Karunai Chooranam: 1 gram of Kattu Karunai Chooranam is administered twice a day with cows butter milk for 48 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Patients with appropriate symptoms like Bleeding during defecation Constipation Pain in anal region Per rectal examination pile mass present

Exclusion criteria

Exclusion criteria: Pregnant and lactating mothers Second degree haemorrhoids External haemorrhoids Fissure in ano Fistula Ca Rectum Rectal Prolapse Hb less than 8mg/dl

Design outcomes

Primary

Measure	Time frame
Outcome is mainly assessed byreduction in clinical symptoms measured by reduction in pain, cessation of bleeding during defecation constipationTimepoint: 48 days	—

Secondary

Measure	Time frame
Secondary outcome is comparing the safety parameters before and after treatmentTimepoint: 48 days	—

Countries

India

Contacts

Public ContactDr priya s

Government siddha medical college

chittu758@gmail.com9444177230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026